- Home
- NUWE vs BDRX Comparison
NUWE vs BDRX Comparison
Compare NUWE & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- BDRX
- Stock Information
- Founded
- NUWE 1999
- BDRX 2000
- Country
- NUWE United States
- BDRX United Kingdom
- Employees
- NUWE N/A
- BDRX N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- BDRX Health Care
- Exchange
- NUWE Nasdaq
- BDRX Nasdaq
- Market Cap
- NUWE 3.9M
- BDRX 3.6M
- IPO Year
- NUWE N/A
- BDRX N/A
- Fundamental
- Price
- NUWE $0.40
- BDRX $1.15
- Analyst Decision
- NUWE Strong Buy
- BDRX
- Analyst Count
- NUWE 1
- BDRX 0
- Target Price
- NUWE $17.00
- BDRX N/A
- AVG Volume (30 Days)
- NUWE 187.8K
- BDRX 3.6M
- Earning Date
- NUWE 05-13-2025
- BDRX 04-11-2025
- Dividend Yield
- NUWE N/A
- BDRX N/A
- EPS Growth
- NUWE N/A
- BDRX N/A
- EPS
- NUWE N/A
- BDRX N/A
- Revenue
- NUWE $8,787,000.00
- BDRX N/A
- Revenue This Year
- NUWE $26.81
- BDRX N/A
- Revenue Next Year
- NUWE $48.74
- BDRX N/A
- P/E Ratio
- NUWE N/A
- BDRX N/A
- Revenue Growth
- NUWE N/A
- BDRX N/A
- 52 Week Low
- NUWE $0.40
- BDRX $1.01
- 52 Week High
- NUWE $8.40
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- NUWE 15.96
- BDRX 39.66
- Support Level
- NUWE $0.76
- BDRX $1.01
- Resistance Level
- NUWE $0.95
- BDRX $1.26
- Average True Range (ATR)
- NUWE 0.09
- BDRX 0.12
- MACD
- NUWE -0.05
- BDRX 0.01
- Stochastic Oscillator
- NUWE 0.00
- BDRX 15.22
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.